Evolution of advanced revascularization strategies for high-risk pulmonary embolism: a physiology-guided single-center experience - Top-Institutions - MDSpire

Evolution of advanced revascularization strategies for high-risk pulmonary embolism: a physiology-guided single-center experience

  • By

  • L. W. Greenspon

  • S. Whealon

  • J. Bonn

  • M. Caroline

  • E. Gnall

  • June 10, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Urokinase Pulmonary Embolism Trial (UPET)
    Urokinase Pulmonary Embolism Trial (UPET)

    N/A, N/A

    Key Differentiators

    • Pulmonology

  • #2

    PEITHO trial
    PEITHO trial

    N/A, N/A

    Key Differentiators

    • Pulmonology

  • #3

    MOPETT trial
    MOPETT trial

    N/A, N/A

    Key Differentiators

    • Pulmonology

  • #4

    PREPIC-1 trial
    PREPIC-1 trial

    N/A, N/A

    Key Differentiators

    • Pulmonology

  • #5

    PREPIC-2 trial
    PREPIC-2 trial

    N/A, N/A

    Key Differentiators

    • Pulmonology

Original Source(s)

Evolution of advanced revascularization strategies for high-risk pulmonary embolism: a physiology-guided single-center experience

  • by L. W. Greenspon, S. Whealon, J. Bonn, M. Caroline, E. Gnall

  • June 10, 2026

Related Content

AI-Powered Resting 12-Lead Electrocardiogram Algorithm for Predicting Low Peak Oxygen Consumption: Development and Validation Study

Comorbidity sequence, sex, and APOE-genotype forecast Alzheimer's disease diagnosis

Investigational Drug Shows Potentialin Phase 3 Obesity Trial

In a 76-week randomized trial, patients with obesity without diabetes who received survodutide achieved greater weight loss and favorable changes in several metabolic measures compared with those who received placebo.